| abstract |
PROBLEM TO BE SOLVED: To provide methods for treating, pre-treating or preconditioning or preventing erythropoietin-related conditions, as well as compounds used in these methods, and methods for identifying such compounds. Compounds that increase endogenous erythropoietin in vitro and in vivo, such as those selected from the group consisting of heterocyclic carboxamides, phenanthrolines, hydroxamates and physiologically active salts and prodrugs derived therefrom It is. [Selection figure] None |